Reference
WHO. Tocilizumab and Cutaneous Vasculitis. WHO Pharmaceuticals Newsletter : Sep 2020. Available from: URL: https://www.who.int/publications/i/item/9789240010741
Rights and permissions
About this article
Cite this article
Evidence of association between tocilizumab and cutaneous vasculitis. Reactions Weekly 1823, 1 (2020). https://doi.org/10.1007/s40278-020-83629-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-83629-y